Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Pae, Chi-Un
Drago, Antonio
Mandelli, Laura
De Ronchi, Diana
and
Serretti, Alessandro
2009.
TAAR 6 and HSP-70 variations associated with bipolar disorder.
Neuroscience Letters,
Vol. 465,
Issue. 3,
p.
257.
Whitworth, Alexander J.
and
Pallanck, Leo J.
2009.
The PINK1/Parkin pathway: a mitochondrial quality control system?.
Journal of Bioenergetics and Biomembranes,
Vol. 41,
Issue. 6,
p.
499.
Jendrach, Marina
Gispert, Suzana
Ricciardi, Filomena
Klinkenberg, Michael
Schemm, Rudolf
and
Auburger, Georg
2009.
The mitochondrial kinase PINK1, stress response and Parkinson’s disease.
Journal of Bioenergetics and Biomembranes,
Vol. 41,
Issue. 6,
p.
481.
Haugarvoll, Kristoffer
and
Wszolek, Zbigniew K.
2009.
Clinical features of LRRK2 parkinsonism.
Parkinsonism & Related Disorders,
Vol. 15,
Issue. ,
p.
S205.
Jucker, Mathias
2010.
The benefits and limitations of animal models for translational research in neurodegenerative diseases.
Nature Medicine,
Vol. 16,
Issue. 11,
p.
1210.
Cookson, M. R.
and
Bandmann, O.
2010.
Parkinson's disease: insights from pathways.
Human Molecular Genetics,
Vol. 19,
Issue. R1,
p.
R21.
Greten-Harrison, Becket
Polydoro, Manuela
Morimoto-Tomita, Megumi
Diao, Ling
Williams, Andrew M.
Nie, Esther H.
Makani, Sachin
Tian, Ning
Castillo, Pablo E.
Buchman, Vladimir L.
and
Chandra, Sreeganga S.
2010.
αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction.
Proceedings of the National Academy of Sciences,
Vol. 107,
Issue. 45,
p.
19573.
Saijo, Kaoru
Crotti, Andrea
and
Glass, Christopher K.
2010.
Vol. 106,
Issue. ,
p.
21.
Glass, Christopher K.
Saijo, Kaoru
Winner, Beate
Marchetto, Maria Carolina
and
Gage, Fred H.
2010.
Mechanisms Underlying Inflammation in Neurodegeneration.
Cell,
Vol. 140,
Issue. 6,
p.
918.
Dawson, Ted M.
Ko, Han Seok
and
Dawson, Valina L.
2010.
Genetic Animal Models of Parkinson's Disease.
Neuron,
Vol. 66,
Issue. 5,
p.
646.
Gasser, Thomas
2010.
Recent Advances in Parkinson’s Disease: Basic Research.
Vol. 183,
Issue. ,
p.
2.
Venda, Lara Lourenço
Cragg, Stephanie J.
Buchman, Vladimir L.
and
Wade-Martins, Richard
2010.
α-Synuclein and dopamine at the crossroads of Parkinson's disease.
Trends in Neurosciences,
Vol. 33,
Issue. 12,
p.
559.
Taymans, Jean‐Marc
and
Cookson, Mark R.
2010.
Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, α‐synuclein, and tau.
BioEssays,
Vol. 32,
Issue. 3,
p.
227.
Lee, H.
Melrose, H.L.
Yue, M.
Pare, Jean-Francois
Farrer, M.J.
and
Smith, Y.
2010.
Lrrk2 localization in the primate basal ganglia and thalamus: A light and electron microscopic analysis in monkeys.
Experimental Neurology,
Vol. 224,
Issue. 2,
p.
438.
Cookson, Mark R.
2010.
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.
Nature Reviews Neuroscience,
Vol. 11,
Issue. 12,
p.
791.
Mellick, George D
Silburn, Peter A
Sutherland, Greg T
and
Siebert, Gerhard A
2010.
Exploiting the potential of molecular profiling in Parkinson’s disease: current practice and future probabilities.
Expert Review of Molecular Diagnostics,
Vol. 10,
Issue. 8,
p.
1035.
Lacoste, Arnaud
and
Burcin, Mark
2010.
Human Stem Cell Technology and Biology.
p.
353.
Bonifati, Vincenzo
2010.
Shaking the genome: new studies reveal genetic risk for Parkinson's disease.
The Lancet Neurology,
Vol. 9,
Issue. 2,
p.
136.
Ko, Han Seok
Lee, Yunjong
Shin, Joo-Ho
Karuppagounder, Senthilkumar S.
Gadad, Bharathi Shrikanth
Koleske, Anthony J.
Pletnikova, Olga
Troncoso, Juan C.
Dawson, Valina L.
and
Dawson, Ted M.
2010.
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Proceedings of the National Academy of Sciences,
Vol. 107,
Issue. 38,
p.
16691.
Boutten, A
Goven, D
Boczkowski, J
and
Bonay, M
2010.
Oxidative stress targets in pulmonary emphysema: focus on the Nrf2 pathway.
Expert Opinion on Therapeutic Targets,
Vol. 14,
Issue. 3,
p.
329.